Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3998953 | Surgical Oncology Clinics of North America | 2007 | 13 Pages |
Abstract
A multidisciplinary team is essential for the optimal management of patients with metastatic neuroendocrine tumors. In this article, the systemic and regional nonsurgical therapeutic options for metastatic neuroendocrine cancers are discussed. In particular, the roles of biotherapy, chemotherapy, and hepatic artery embolization/chemoembolization are reviewed. A proposed treatment algorithm is provided with the aim of providing clinicians with a useful framework for managing these challenging patients. Finally, the rationale for promising investigational therapies is described.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Eric K. Nakakura, Alan P. Venook, Emily K. Bergsland,